Peter Milligan

Peter Milligan, Ph.D.

Chief Executive Officer

  • Joined Pharmetheus in 2019, serving as managing director for the business, responsible to the Board.
  • Expertise includes pre-clinical and clinical pharmacology and pharmacometrics in therapeutic areas such as oncology, neuroscience, and infectious, gastrointestinal, and cardiovascular diseases.
  • Experience as Head of Global Pharmacokinetics at Pfizer UK, where he led model informed drug development implementation across Pfizer to develop integrated analyses of relevant data informing strategy, design, and decision making in drug discovery and development. Previously, he worked as Staff Researcher at Syntex, UK.
  • M.Sc. in Clinical Pharmacy (1987) from Strathclyde University, UK, and Ph.D. in Medicine and Therapeutics (1991) from Glasgow University, UK.